Takeda Pharmaceutical Company Ltd is the largest pharmaceutical company in Japan and Asia and a top 15 pharmaceutical company in the world. The company has over 30,000 employees worldwide and achieved 16.2 billion USD in revenue during the 2012 fiscal year. The company is focused on metabolic disorders, ...
Holding Company. Address : 767 Third Avenue, New York, NY 10017, USA. Telephone Number : +1-212-421-6954. Fax Number : +1-212-355-5243. Founded : 1997. As a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Takeda America Holdings, Inc. handles cash management and investment ...
Company Overview. Takeda America Holdings, Inc. is an investment holding company. The company, through its subsidiaries, researches, discovers, and develops molecular drugs for neurological and psychiatric diseases, and for the treatment of cancer. The company handles cash management and investment activities.
Takeda's U.S. clinical development activities are conducted via Takeda Development Center Americas, Inc., which has a robust pipeline of compounds in multiple therapeutic areas including metabolic and cardiovascular diseases, central nervous system, respiratory and immunology, oncology and general medicine.
General info: Founded in 1997, Takeda America Holdings offers various cash management and investment services. Located in New York City, Takeda America Holdings is a wholly owned subsidiary of Takeda Pharmaceutical Company, which discovers, develops, manufactures and markets a broad range of ...
Get information, directions, products, services, phone numbers, and reviews on Takeda America Holdings in New York, NY. Discover more Drugs, Drug Proprietaries, and Druggists' Sundries companies in New York on Manta.com.
TAKEDA AMERICA HOLDINGS, INC. a wholly-owned subsidiary of. TAKEDA PHARMACEUTICAL COMPANY LIMITED (Names of Filing Persons (Offerors)). COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) . 599902103 (CUSIP Number of Class of Securities). Iwaaki Taniguchi President
OSAKA, Japan and DEERFIELD, Ill. and FORT COLLINS, Colo., May 7, 2013 / PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and Inviragen, Inc. ("Inviragen") jointly announced today that Takeda, its wholly owned subsidiary Takeda America Holdings, Inc., and Inviragen, Inc. have entered into a ...
Jun 24, 2009 ... With the consummation of the merger, IDM has become a wholly owned subsidiary of Takeda America Holdings, Inc. This acquisition adds MEPACT® ( mifamurtide), a novel therapy indicated for the treatment of osteosarcoma, to the Takeda oncology portfolio in Europe. “With the closing of this acquisition, ...